{"id":"W2066557153","doi":"10.1007/s10637-011-9673-x","title":"A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gemcitabine; Eribulin; Medicine; Internal medicine; Pancreatic cancer; Neutropenia; Gastroenterology; Phases of clinical research; Oncology; Progressive disease; Clinical endpoint; Refractory (planetary science); Adverse effect; Cancer; Metastatic breast cancer; Chemotherapy; Breast cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001077588,0.0001589672,0.0003194728,0.0001145335,0.00006443946,0.000002414036,0.0001231519,0.00005114227,0.000867384],"category_scores_gemma":[0.00005415173,0.0001153094,0.00006331398,0.0004234285,0.0001341855,0.00009087833,0.00005507292,0.0001883152,0.000006850492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001527808,"about_ca_system_score_gemma":0.0005666151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004271796,"about_ca_topic_score_gemma":0.001461599,"domain_scores_codex":[0.9988371,0.00008410098,0.0003844152,0.0002448666,0.0002681724,0.0001813608],"domain_scores_gemma":[0.9992918,0.00006472622,0.0001826091,0.0002304006,0.00007997769,0.0001504762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007048501,0.02281551,0.7260762,0.0001915087,0.001256365,0.0001307706,0.07618634,0.000411029,0.132327,0.001690646,0.009192495,0.02267366],"study_design_scores_gemma":[0.06230645,0.008702003,0.8796339,0.000439444,0.0009665816,0.00002247334,0.001224264,0.0003310442,0.03085719,0.004899779,0.01019129,0.000425544],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952808,0.000608921,0.000001175525,0.001425483,0.0002172115,0.0008039499,0.00002531392,0.00002136496,0.001615802],"genre_scores_gemma":[0.995181,0.00005497014,0.0003314478,0.0007235621,0.0001053215,0.0001520121,0.00002465692,0.00001696463,0.003410079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1535577,"threshold_uncertainty_score":0.9497247,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04866918016163396,"score_gpt":0.3410725055096305,"score_spread":0.2924033253479966,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}